Medimaging Integrated Solution (TPE:6796) Stock Based Compensation: NT$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6796 Medimaging Integrated Solution Inc TPE:6796
74 GF Score
Price NT$57.90
GF Value NT$106.66
Valuation Significantly Undervalued
! 9 Warning Signs
View Full Analysis

What is Medimaging Integrated Solution Stock Based Compensation?

Medimaging Integrated Solution TPE:6796 +0.52% 74 Stock Based Compensation is NT$0.0 Mil as of Dec. 2025. GuruFocus rates TPE:6796 with a GF Score™ of 74/100 and a GF Value™ of NT$106.66 (Significantly Undervalued). The stock has 9 warning signs investors should review.

Medimaging Integrated Solution's Stock Based Compensation for the three months ended in Dec. 2025 was NT$0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.0 Mil.

Medimaging Integrated Solution Stock Based Compensation Related Terms

Medimaging Integrated Solution Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Medimaging Integrated Solution's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medimaging Integrated Solution Stock Based Compensation Chart

Medimaging Integrated Solution Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 0.66 0.50 2.96 0.08 0.00

Medimaging Integrated Solution Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TPE:6796
74GF Score
Medimaging Integrated Solution Inc TPE:6796
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medimaging Integrated Solution Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

What does a Stock Based Compensation of NT$0.0 Mil mean?
Medimaging Integrated Solution (TPE:6796) has a Stock Based Compensation of NT$0.0 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Medimaging Integrated Solution and its competitors.
Is Medimaging Integrated Solution's Stock Based Compensation too high?
Medimaging Integrated Solution's current Stock Based Compensation is NT$0.0 Mil. Overall, Medimaging Integrated Solution has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medimaging Integrated Solution's Stock Based Compensation compare to ABT and SYK?
Medimaging Integrated Solution's Stock Based Compensation of NT$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Medimaging Integrated Solution and its competitors. Medimaging Integrated Solution's current Stock Based Compensation is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medimaging Integrated Solution stock overvalued right now?
Based on GuruFocus' analysis, Medimaging Integrated Solution (TPE:6796) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$106.66, compared to a current price of NT$57.90 — trading 45.7% below its estimated fair value. The current Stock Based Compensation is NT$0.0 Mil. Medimaging Integrated Solution's overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Medimaging Integrated Solution (TPE:6796), the current Stock Based Compensation is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medimaging Integrated Solution (TPE:6796) Overvalued in 2026?

Based on GuruFocus' analysis, Medimaging Integrated Solution stock appears to be undervalued. The current stock price of NT$57.90 is trading 45.7% below its estimated GF Value™ of NT$106.66. GuruFocus considers Medimaging Integrated Solution to be Significantly Undervalued.

Key valuation signals for TPE:6796:

  • Stock Based Compensation: NT$0.0 Mil
  • GF Value™: NT$106.66 vs. price of NT$57.90 (45.7% below fair value)
  • GF Score™: 74/100 with 9 warning signs

No single metric tells the full story. See the TPE:6796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medimaging Integrated Solution Business Description

Address No.24-2, Industry E. Road IV, 3rd Floor, Hsinchu Science Park, Hsinchu, TWN, 30077
Medimaging Integrated Solution Inc and its subsidiaries are engaged in the design, manufacturing, and sales of digital medical imaging diagnostic equipment and related products and services. The company is a trusted partner of hospitals, medical schools, and health organizations, providing practitioners with digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes. Its products include Horus Scope, Smart Solutions, Endoscopy, and Micro Camera Modules.
74GF Score

Get the complete analysis for TPE:6796

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$57.90
Price
NT$106.66
GF Value